Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

Overview of attention for article published in BMC Cancer, June 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 62 Mendeley

Summary Policy documents X Reddit Dimensions citations

So far, Altmetric has seen 1 X post from an account with 219 followers.

#Céritinib et #alectinib: analyse poolée de la tolérance clinique dans le CBNPC ALK-positif https://t.co/s3ja6cnCdu

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.